Interestingly, compared with the control cohort, the Barx2 knock-down cohort showed higher E-cadherin and lower vimentin expression in IHC staining of tumor xenografts, confirming our hypothesis that Barx2 acts as a cancer suppressor gene in GC. The gene discussed is VIM; the disease is neoplasm.